Glucose Meter Market By Type (Traditional Glucose Meters, Smart Glucose Meters) , By End User (Hospitals, Clinics, Home Care Settings) : Global Opportunity Analysis and Industry Forecast, 2024-2033
The glucose meter market was valued at $1.0 billion in 2023, and is projected to reach $1.7 billion by 2033, growing at a CAGR of 5.4% from 2024 to 2033.
A glucose meter, also known as a glucometer, is a portable medical device designed to measure the concentration of glucose in the blood. It is commonly used by individuals with diabetes to monitor their blood sugar levels, helping them manage their condition effectively. The device requires a small blood sample, obtained via a finger prick, which is then analyzed to provide real-time glucose readings.
The global glucose meter market is witnessing robust growth due to factors such as increase in public awareness about the importance of regular blood glucose monitoring and early diagnosis and alarming rise in prevalence of diabetes driven by sedentary lifestyle and unhealthy diets. As per a study published in 2021 by the International Diabetes Federation (IDF), approximately 537 million adults (20-79 years) were suffering from diabetes. This number is estimated to reach 643 million by 2030 and 783 million by 2045. This highlights the urgent need for glucose meters for continuous monitoring of glucose levels. In addition, rise in preference for home-based healthcare solutions has driven the demand for portable and easy-to-use glucose meters, thereby fostering the market growth. Furthermore, surge in geriatric population acts as a key driving force of the global market. This is attributed to the fact that the aging population is more susceptible to diabetes and related complications, creating a growing need for efficient glucose monitoring solutions. A 2024 study published by the World Health Organization revealed that the number of aged individuals will increase from 1 billion in 2020 to 1.4 billion by 2030. Moreover, the number of individuals aging 80 years and older is estimated to reach 426 million by 2050. Improved healthcare infrastructure and rise in disposable incomes in emerging markets have further enhanced access to glucose monitoring devices, driving the market growth. However, high cost associated with advanced glucose monitoring systems, such as continuous glucose monitors, restrains the market growth. In addition, lack awareness about diabetes management and the importance of regular glucose monitoring limits the demand for glucose meters. On the contrary, the development of innovative glucose monitoring technologies, such as continuous glucose monitors, smartphone-compatible meters, and non-invasive devices has enhanced accuracy, convenience, and user-friendliness. Such developments are expected to open new avenues for the expansion of the global market during the forecast period.
The global glucose meter industry is segmented into type, end user, and region. On the basis of type, the market is categorized into traditional glucose meters and smart glucose meters. Depending on end user, it is segregated into hospitals, clinics, and home care settings. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Key Findings
By type, the traditional glucose meters segment is expected to dominate the market from 2024 to 2033.
On the basis of end user, the hospitals segment is anticipated to exhibit the highest growth during the forecast period.
Region wise, the blood glucose meter market is projected to show strong growth in North America in the coming years.
Competition Analysis
The major players operating in the global glucose meter market include B. Braun SE, F. Hoffmann-La Roche Ltd, AgaMatrix, Inc, Ascensia Diabetes Care, LifeScan IP Holdings, LLC., Medtronic, Dexcom, Inc., Ypsomed., Abbott Laboratories, and Terumo Corporation. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships to sustain the intense competition and gain a strong foothold in the global market.
Key Market Segments
By Type
Traditional Glucose Meters
Smart Glucose Meters
By End User
Hospitals
Clinics
Home Care Settings
By Region
North America
U.S.
Canada
Mexico
Europe
France
Germany
Italy
Spain
UK
Rest of Europe
Asia-Pacific
China
Japan
India
South Korea
Australia
Rest of Asia-Pacific
LAMEA
Brazil
South Africa
Saudi Arabia
Rest of LAMEA
Key Market Players
B. Braun SE
F. Hoffmann-La Roche Ltd
AgaMatrix, Inc
Ascensia Diabetes Care
LifeScan IP Holdings, LLC.
Medtronic
Dexcom, Inc.
Ypsomed.
Abbott Laboratories
Terumo Corporation
- CHAPTER 1: INTRODUCTION
- 1.1. Report Description
- 1.2. Key Market Segments
- 1.3. Key Benefits
- 1.4. Research Methodology
- 1.4.1. Primary Research
- 1.4.2. Secondary Research
- 1.4.3. Analyst Tools and Models
- CHAPTER 2: EXECUTIVE SUMMARY
- 2.1. CXO Perspective
- CHAPTER 3: MARKET LANDSCAPE
- 3.1. Market Definition and Scope
- 3.2. Key Findings
- 3.2.1. Top Investment Pockets
- 3.2.2. Top Winning Strategies
- 3.3. Porter's Five Forces Analysis
- 3.3.1. Bargaining Power of Suppliers
- 3.3.2. Threat of New Entrants
- 3.3.3. Threat of Substitutes
- 3.3.4. Competitive Rivalry
- 3.3.5. Bargaining Power among Buyers
- 3.4. Market Dynamics
- 3.4.1. Drivers
- 3.4.2. Restraints
- 3.4.3. Opportunities
- CHAPTER 4: GLUCOSE METER MARKET, BY TYPE
- 4.1. Market Overview
- 4.1.1 Market Size and Forecast, By Type
- 4.2. Traditional Glucose Meters
- 4.2.1. Key Market Trends, Growth Factors and Opportunities
- 4.2.2. Market Size and Forecast, By Region
- 4.2.3. Market Share Analysis, By Country
- 4.3. Smart Glucose Meters
- 4.3.1. Key Market Trends, Growth Factors and Opportunities
- 4.3.2. Market Size and Forecast, By Region
- 4.3.3. Market Share Analysis, By Country
- CHAPTER 5: GLUCOSE METER MARKET, BY END USER
- 5.1. Market Overview
- 5.1.1 Market Size and Forecast, By End User
- 5.2. Hospitals
- 5.2.1. Key Market Trends, Growth Factors and Opportunities
- 5.2.2. Market Size and Forecast, By Region
- 5.2.3. Market Share Analysis, By Country
- 5.3. Clinics
- 5.3.1. Key Market Trends, Growth Factors and Opportunities
- 5.3.2. Market Size and Forecast, By Region
- 5.3.3. Market Share Analysis, By Country
- 5.4. Home Care Settings
- 5.4.1. Key Market Trends, Growth Factors and Opportunities
- 5.4.2. Market Size and Forecast, By Region
- 5.4.3. Market Share Analysis, By Country
- CHAPTER 6: GLUCOSE METER MARKET, BY REGION
- 6.1. Market Overview
- 6.1.1 Market Size and Forecast, By Region
- 6.2. North America
- 6.2.1. Key Market Trends and Opportunities
- 6.2.2. Market Size and Forecast, By Type
- 6.2.3. Market Size and Forecast, By End User
- 6.2.4. Market Size and Forecast, By Country
- 6.2.5. U.S. Glucose Meter Market
- 6.2.5.1. Market Size and Forecast, By Type
- 6.2.5.2. Market Size and Forecast, By End User
- 6.2.6. Canada Glucose Meter Market
- 6.2.6.1. Market Size and Forecast, By Type
- 6.2.6.2. Market Size and Forecast, By End User
- 6.2.7. Mexico Glucose Meter Market
- 6.2.7.1. Market Size and Forecast, By Type
- 6.2.7.2. Market Size and Forecast, By End User
- 6.3. Europe
- 6.3.1. Key Market Trends and Opportunities
- 6.3.2. Market Size and Forecast, By Type
- 6.3.3. Market Size and Forecast, By End User
- 6.3.4. Market Size and Forecast, By Country
- 6.3.5. France Glucose Meter Market
- 6.3.5.1. Market Size and Forecast, By Type
- 6.3.5.2. Market Size and Forecast, By End User
- 6.3.6. Germany Glucose Meter Market
- 6.3.6.1. Market Size and Forecast, By Type
- 6.3.6.2. Market Size and Forecast, By End User
- 6.3.7. Italy Glucose Meter Market
- 6.3.7.1. Market Size and Forecast, By Type
- 6.3.7.2. Market Size and Forecast, By End User
- 6.3.8. Spain Glucose Meter Market
- 6.3.8.1. Market Size and Forecast, By Type
- 6.3.8.2. Market Size and Forecast, By End User
- 6.3.9. UK Glucose Meter Market
- 6.3.9.1. Market Size and Forecast, By Type
- 6.3.9.2. Market Size and Forecast, By End User
- 6.3.10. Rest Of Europe Glucose Meter Market
- 6.3.10.1. Market Size and Forecast, By Type
- 6.3.10.2. Market Size and Forecast, By End User
- 6.4. Asia-Pacific
- 6.4.1. Key Market Trends and Opportunities
- 6.4.2. Market Size and Forecast, By Type
- 6.4.3. Market Size and Forecast, By End User
- 6.4.4. Market Size and Forecast, By Country
- 6.4.5. China Glucose Meter Market
- 6.4.5.1. Market Size and Forecast, By Type
- 6.4.5.2. Market Size and Forecast, By End User
- 6.4.6. Japan Glucose Meter Market
- 6.4.6.1. Market Size and Forecast, By Type
- 6.4.6.2. Market Size and Forecast, By End User
- 6.4.7. India Glucose Meter Market
- 6.4.7.1. Market Size and Forecast, By Type
- 6.4.7.2. Market Size and Forecast, By End User
- 6.4.8. South Korea Glucose Meter Market
- 6.4.8.1. Market Size and Forecast, By Type
- 6.4.8.2. Market Size and Forecast, By End User
- 6.4.9. Australia Glucose Meter Market
- 6.4.9.1. Market Size and Forecast, By Type
- 6.4.9.2. Market Size and Forecast, By End User
- 6.4.10. Rest of Asia-Pacific Glucose Meter Market
- 6.4.10.1. Market Size and Forecast, By Type
- 6.4.10.2. Market Size and Forecast, By End User
- 6.5. LAMEA
- 6.5.1. Key Market Trends and Opportunities
- 6.5.2. Market Size and Forecast, By Type
- 6.5.3. Market Size and Forecast, By End User
- 6.5.4. Market Size and Forecast, By Country
- 6.5.5. Brazil Glucose Meter Market
- 6.5.5.1. Market Size and Forecast, By Type
- 6.5.5.2. Market Size and Forecast, By End User
- 6.5.6. South Africa Glucose Meter Market
- 6.5.6.1. Market Size and Forecast, By Type
- 6.5.6.2. Market Size and Forecast, By End User
- 6.5.7. Saudi Arabia Glucose Meter Market
- 6.5.7.1. Market Size and Forecast, By Type
- 6.5.7.2. Market Size and Forecast, By End User
- 6.5.8. Rest of LAMEA Glucose Meter Market
- 6.5.8.1. Market Size and Forecast, By Type
- 6.5.8.2. Market Size and Forecast, By End User
- CHAPTER 7: COMPETITIVE LANDSCAPE
- 7.1. Introduction
- 7.2. Top Winning Strategies
- 7.3. Product Mapping Of Top 10 Player
- 7.4. Competitive Dashboard
- 7.5. Competitive Heatmap
- 7.6. Top Player Positioning, 2023
- CHAPTER 8: COMPANY PROFILES
- 8.1. B. Braun SE
- 8.1.1. Company Overview
- 8.1.2. Key Executives
- 8.1.3. Company Snapshot
- 8.1.4. Operating Business Segments
- 8.1.5. Product Portfolio
- 8.1.6. Business Performance
- 8.1.7. Key Strategic Moves and Developments
- 8.2. F. Hoffmann-La Roche Ltd
- 8.2.1. Company Overview
- 8.2.2. Key Executives
- 8.2.3. Company Snapshot
- 8.2.4. Operating Business Segments
- 8.2.5. Product Portfolio
- 8.2.6. Business Performance
- 8.2.7. Key Strategic Moves and Developments
- 8.3. AgaMatrix, Inc
- 8.3.1. Company Overview
- 8.3.2. Key Executives
- 8.3.3. Company Snapshot
- 8.3.4. Operating Business Segments
- 8.3.5. Product Portfolio
- 8.3.6. Business Performance
- 8.3.7. Key Strategic Moves and Developments
- 8.4. Ascensia Diabetes Care
- 8.4.1. Company Overview
- 8.4.2. Key Executives
- 8.4.3. Company Snapshot
- 8.4.4. Operating Business Segments
- 8.4.5. Product Portfolio
- 8.4.6. Business Performance
- 8.4.7. Key Strategic Moves and Developments
- 8.5. LifeScan IP Holdings, LLC.
- 8.5.1. Company Overview
- 8.5.2. Key Executives
- 8.5.3. Company Snapshot
- 8.5.4. Operating Business Segments
- 8.5.5. Product Portfolio
- 8.5.6. Business Performance
- 8.5.7. Key Strategic Moves and Developments
- 8.6. Medtronic
- 8.6.1. Company Overview
- 8.6.2. Key Executives
- 8.6.3. Company Snapshot
- 8.6.4. Operating Business Segments
- 8.6.5. Product Portfolio
- 8.6.6. Business Performance
- 8.6.7. Key Strategic Moves and Developments
- 8.7. Dexcom, Inc.
- 8.7.1. Company Overview
- 8.7.2. Key Executives
- 8.7.3. Company Snapshot
- 8.7.4. Operating Business Segments
- 8.7.5. Product Portfolio
- 8.7.6. Business Performance
- 8.7.7. Key Strategic Moves and Developments
- 8.8. Ypsomed.
- 8.8.1. Company Overview
- 8.8.2. Key Executives
- 8.8.3. Company Snapshot
- 8.8.4. Operating Business Segments
- 8.8.5. Product Portfolio
- 8.8.6. Business Performance
- 8.8.7. Key Strategic Moves and Developments
- 8.9. Abbott Laboratories
- 8.9.1. Company Overview
- 8.9.2. Key Executives
- 8.9.3. Company Snapshot
- 8.9.4. Operating Business Segments
- 8.9.5. Product Portfolio
- 8.9.6. Business Performance
- 8.9.7. Key Strategic Moves and Developments
- 8.10. Terumo Corporation
- 8.10.1. Company Overview
- 8.10.2. Key Executives
- 8.10.3. Company Snapshot
- 8.10.4. Operating Business Segments
- 8.10.5. Product Portfolio
- 8.10.6. Business Performance
- 8.10.7. Key Strategic Moves and Developments
- LIST OF TABLES
- TABLE 1. GLOBAL GLUCOSE METER MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 2. GLUCOSE METER MARKET FOR TRADITIONAL GLUCOSE METERS, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 3. GLUCOSE METER MARKET FOR SMART GLUCOSE METERS, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 4. GLOBAL GLUCOSE METER MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 5. GLUCOSE METER MARKET FOR HOSPITALS, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 6. GLUCOSE METER MARKET FOR CLINICS, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 7. GLUCOSE METER MARKET FOR HOME CARE SETTINGS, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 8. GLUCOSE METER MARKET, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 9. NORTH AMERICA GLUCOSE METER MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
- TABLE 10. NORTH AMERICA GLUCOSE METER MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 11. NORTH AMERICA GLUCOSE METER MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 12. U.S. GLUCOSE METER MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 13. U.S. GLUCOSE METER MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 14. CANADA GLUCOSE METER MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 15. CANADA GLUCOSE METER MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 16. MEXICO GLUCOSE METER MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 17. MEXICO GLUCOSE METER MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 18. EUROPE GLUCOSE METER MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
- TABLE 19. EUROPE GLUCOSE METER MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 20. EUROPE GLUCOSE METER MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 21. FRANCE GLUCOSE METER MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 22. FRANCE GLUCOSE METER MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 23. GERMANY GLUCOSE METER MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 24. GERMANY GLUCOSE METER MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 25. ITALY GLUCOSE METER MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 26. ITALY GLUCOSE METER MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 27. SPAIN GLUCOSE METER MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 28. SPAIN GLUCOSE METER MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 29. UK GLUCOSE METER MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 30. UK GLUCOSE METER MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 31. REST OF EUROPE GLUCOSE METER MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 32. REST OF EUROPE GLUCOSE METER MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 33. ASIA-PACIFIC GLUCOSE METER MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
- TABLE 34. ASIA-PACIFIC GLUCOSE METER MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 35. ASIA-PACIFIC GLUCOSE METER MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 36. CHINA GLUCOSE METER MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 37. CHINA GLUCOSE METER MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 38. JAPAN GLUCOSE METER MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 39. JAPAN GLUCOSE METER MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 40. INDIA GLUCOSE METER MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 41. INDIA GLUCOSE METER MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 42. SOUTH KOREA GLUCOSE METER MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 43. SOUTH KOREA GLUCOSE METER MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 44. AUSTRALIA GLUCOSE METER MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 45. AUSTRALIA GLUCOSE METER MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 46. REST OF ASIA-PACIFIC GLUCOSE METER MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 47. REST OF ASIA-PACIFIC GLUCOSE METER MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 48. LAMEA GLUCOSE METER MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
- TABLE 49. LAMEA GLUCOSE METER MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 50. LAMEA GLUCOSE METER MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 51. BRAZIL GLUCOSE METER MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 52. BRAZIL GLUCOSE METER MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 53. SOUTH AFRICA GLUCOSE METER MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 54. SOUTH AFRICA GLUCOSE METER MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 55. SAUDI ARABIA GLUCOSE METER MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 56. SAUDI ARABIA GLUCOSE METER MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 57. REST OF LAMEA GLUCOSE METER MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 58. REST OF LAMEA GLUCOSE METER MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 59. B. BRAUN SE: KEY EXECUTIVES
- TABLE 60. B. BRAUN SE: COMPANY SNAPSHOT
- TABLE 61. B. BRAUN SE: OPERATING SEGMENTS
- TABLE 62. B. BRAUN SE: PRODUCT PORTFOLIO
- TABLE 63. B. BRAUN SE: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 64. F. HOFFMANN-LA ROCHE LTD: KEY EXECUTIVES
- TABLE 65. F. HOFFMANN-LA ROCHE LTD: COMPANY SNAPSHOT
- TABLE 66. F. HOFFMANN-LA ROCHE LTD: OPERATING SEGMENTS
- TABLE 67. F. HOFFMANN-LA ROCHE LTD: PRODUCT PORTFOLIO
- TABLE 68. F. HOFFMANN-LA ROCHE LTD: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 69. AGAMATRIX, INC: KEY EXECUTIVES
- TABLE 70. AGAMATRIX, INC: COMPANY SNAPSHOT
- TABLE 71. AGAMATRIX, INC: OPERATING SEGMENTS
- TABLE 72. AGAMATRIX, INC: PRODUCT PORTFOLIO
- TABLE 73. AGAMATRIX, INC: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 74. ASCENSIA DIABETES CARE: KEY EXECUTIVES
- TABLE 75. ASCENSIA DIABETES CARE: COMPANY SNAPSHOT
- TABLE 76. ASCENSIA DIABETES CARE: OPERATING SEGMENTS
- TABLE 77. ASCENSIA DIABETES CARE: PRODUCT PORTFOLIO
- TABLE 78. ASCENSIA DIABETES CARE: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 79. LIFESCAN IP HOLDINGS, LLC.: KEY EXECUTIVES
- TABLE 80. LIFESCAN IP HOLDINGS, LLC.: COMPANY SNAPSHOT
- TABLE 81. LIFESCAN IP HOLDINGS, LLC.: OPERATING SEGMENTS
- TABLE 82. LIFESCAN IP HOLDINGS, LLC.: PRODUCT PORTFOLIO
- TABLE 83. LIFESCAN IP HOLDINGS, LLC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 84. MEDTRONIC: KEY EXECUTIVES
- TABLE 85. MEDTRONIC: COMPANY SNAPSHOT
- TABLE 86. MEDTRONIC: OPERATING SEGMENTS
- TABLE 87. MEDTRONIC: PRODUCT PORTFOLIO
- TABLE 88. MEDTRONIC: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 89. DEXCOM, INC.: KEY EXECUTIVES
- TABLE 90. DEXCOM, INC.: COMPANY SNAPSHOT
- TABLE 91. DEXCOM, INC.: OPERATING SEGMENTS
- TABLE 92. DEXCOM, INC.: PRODUCT PORTFOLIO
- TABLE 93. DEXCOM, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 94. YPSOMED.: KEY EXECUTIVES
- TABLE 95. YPSOMED.: COMPANY SNAPSHOT
- TABLE 96. YPSOMED.: OPERATING SEGMENTS
- TABLE 97. YPSOMED.: PRODUCT PORTFOLIO
- TABLE 98. YPSOMED.: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 99. ABBOTT LABORATORIES: KEY EXECUTIVES
- TABLE 100. ABBOTT LABORATORIES: COMPANY SNAPSHOT
- TABLE 101. ABBOTT LABORATORIES: OPERATING SEGMENTS
- TABLE 102. ABBOTT LABORATORIES: PRODUCT PORTFOLIO
- TABLE 103. ABBOTT LABORATORIES: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 104. TERUMO CORPORATION: KEY EXECUTIVES
- TABLE 105. TERUMO CORPORATION: COMPANY SNAPSHOT
- TABLE 106. TERUMO CORPORATION: OPERATING SEGMENTS
- TABLE 107. TERUMO CORPORATION: PRODUCT PORTFOLIO
- TABLE 108. TERUMO CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
- LIST OF FIGURES
- FIGURE 1. GLOBAL GLUCOSE METER MARKET, 2024 - 2033
- FIGURE 2. SEGMENTATION OF GLUCOSE METER MARKET, 2024 - 2033
- FIGURE 3. TOP INVESTMENT POCKET IN GLUCOSE METER MARKET
- FIGURE 4. MODERATE BARGAINING POWER OF BUYERS
- FIGURE 5. MODERATE BARGAINING POWER OF SUPPLIERS
- FIGURE 6. MODERATE THREAT OF NEW ENTRANTS
- FIGURE 7. LOW THREAT OF SUBSTITUTION
- FIGURE 8. HIGH COMPETITIVE RIVALRY
- FIGURE 9. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALGLUCOSE METER MARKET
- FIGURE 10. GLOBAL GLUCOSE METER MARKET SEGMENTATION, BY TYPE
- FIGURE 11. GLUCOSE METER MARKET FOR TRADITIONAL GLUCOSE METERS, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 12. GLUCOSE METER MARKET FOR SMART GLUCOSE METERS, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 13. GLOBAL GLUCOSE METER MARKET SEGMENTATION, BY END USER
- FIGURE 14. GLUCOSE METER MARKET FOR HOSPITALS, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 15. GLUCOSE METER MARKET FOR CLINICS, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 16. GLUCOSE METER MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 17. TOP WINNING STRATEGIES, BY YEAR, 2021-2023*
- FIGURE 18. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2021-2023*
- FIGURE 19. TOP WINNING STRATEGIES, BY COMPANY, 2021-2023*
- FIGURE 20. PRODUCT MAPPING OF TOP 10 PLAYERS
- FIGURE 21. COMPETITIVE DASHBOARD
- FIGURE 22. COMPETITIVE HEATMAP: GLUCOSE METER MARKET
- FIGURE 23. TOP PLAYER POSITIONING, 2023
- FIGURE 24. B. BRAUN SE: NET SALES, 2021-2023 ($BILLION)
- FIGURE 25. B. BRAUN SE: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 26. B. BRAUN SE: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 27. F. HOFFMANN-LA ROCHE LTD: NET SALES, 2021-2023 ($BILLION)
- FIGURE 28. F. HOFFMANN-LA ROCHE LTD: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 29. F. HOFFMANN-LA ROCHE LTD: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 30. AGAMATRIX, INC: NET SALES, 2021-2023 ($BILLION)
- FIGURE 31. AGAMATRIX, INC: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 32. AGAMATRIX, INC: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 33. ASCENSIA DIABETES CARE: NET SALES, 2021-2023 ($BILLION)
- FIGURE 34. ASCENSIA DIABETES CARE: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 35. ASCENSIA DIABETES CARE: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 36. LIFESCAN IP HOLDINGS, LLC.: NET SALES, 2021-2023 ($BILLION)
- FIGURE 37. LIFESCAN IP HOLDINGS, LLC.: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 38. LIFESCAN IP HOLDINGS, LLC.: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 39. MEDTRONIC: NET SALES, 2021-2023 ($BILLION)
- FIGURE 40. MEDTRONIC: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 41. MEDTRONIC: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 42. DEXCOM, INC.: NET SALES, 2021-2023 ($BILLION)
- FIGURE 43. DEXCOM, INC.: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 44. DEXCOM, INC.: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 45. YPSOMED.: NET SALES, 2021-2023 ($BILLION)
- FIGURE 46. YPSOMED.: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 47. YPSOMED.: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 48. ABBOTT LABORATORIES: NET SALES, 2021-2023 ($BILLION)
- FIGURE 49. ABBOTT LABORATORIES: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 50. ABBOTT LABORATORIES: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 51. TERUMO CORPORATION: NET SALES, 2021-2023 ($BILLION)
- FIGURE 52. TERUMO CORPORATION: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 53. TERUMO CORPORATION: REVENUE SHARE, BY REGION, 2023 (%)
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook